Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$195K Hold
462
– – 0.1% 76
2026
Q2
$167K Hold
462
– – 0.08% 75
2026
Q1
$163K Buy
+462
New +$165K 0.09% 76
2025
Q1
– Sell
-462
Closed -$120K – 74
2024
Q4
$120K Hold
462
– – 0.09% 78
2024
Q3
$149K Hold
462
– – 0.11% 73
2024
Q2
$144K Buy
462
+37
+9% +$10.9K 0.12% 70
2024
Q1
$121K Hold
425
– – 0.1% 72
2023
Q4
$122K Hold
425
– – 0.11% 66
2023
Q3
$114K Hold
425
– – 0.11% 63
2023
Q2
$94.4K Hold
425
– – 0.09% 61
2023
Q1
$103K Hold
425
– – 0.1% 62
2022
Q4
$112K Buy
+425
New +$114K 0.11% 61

Other funds holding AMGN

LAM Group's AMGN Position: Q3 2026 in Review

LAM Group held its Amgen (AMGN) position steady in Q3 2026 at 462 shares worth $195K. The position accounts for 0.1% of the portfolio, ranked #76.

LAM Group first reported a position in AMGN in Q4 2022 and has held it in 12 quarters since. 1,494 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • LAM Group held 462 shares of Amgen worth $195K as of Q3 2026.
  • LAM Group left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.1% of LAM Group's portfolio in Q3 2026, its #76 holding.
  • LAM Group first reported a position in Amgen in Q4 2022 and has held it in 12 quarters since.
  • 1,494 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on LAM Group's 13F filing for Q3 2026, filed 26 Oct 2026.